Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05849857
Title Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries (MERLIN)
Acronym MERLIN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oslo University Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries NOR | FIN

Facility Status City State Zip Country Details
Helsinki University Hospital RECRUITING Helsinki Finland Details
Oslo University Hospital RECRUITING Oslo 0424 Norway Details
St. Olavs hospital RECRUITING Trondheim Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field